Oral 5-Aminosalicylate, Mesalamine Suppository, and Mesalamine Enema as Initial Therapy for Ulcerative Proctitis in Clinical Practice with Quality of Care Implications

<div>Cumulative percentage of study subjects experiencing treatment escalation, by duration of follow-up and treatment group. Oral 5-ASA: oral 5-aminosalicylate.</div>

Canadian Journal of Gastroenterology and Hepatology

fig1

Figure 1

Figure 1: Oral 5-Aminosalicylate, Mesalamine Suppository, and Mesalamine Enema as Initial Therapy for Ulcerative Proctitis in Clinical Practice with Quality of Care Implications 

Figure 1 | Oral 5-Aminosalicylate, Mesalamine Suppository, and Mesalamine Enema as Initial Therapy for Ulcerative Proctitis in Clinical Practice with Quality of Care Implications 